Philippe Nobels
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Philippe Nobels
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 26 | |
Price Waterhouse Coopers
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Philippe Nobels
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SOLVAY SA | Chemicals: Specialty | General Counsel | |
| TIGENIX NV | Medical Specialties | Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Director of Finance/CFO | |
| University of Virginia | College/University | Corporate Officer/Principal | |
| University of Pittsburgh | College/University | Corporate Officer/Principal | |
| Wayne State University (Michigan) | College/University | Undergraduate Degree Undergraduate Degree | |
| DELHAIZE GROUP | Food Retail | General Counsel | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Corporate Officer/Principal | |
| University of Leeds | College/University | Doctorate Degree | |
| Yale University | College/University | Corporate Officer/Principal | |
| St. John's University | College/University | Graduate Degree | |
| University of South Florida | College/University | Undergraduate Degree | |
| University Of Dundee | College/University | Doctorate Degree | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Director of Finance/CFO | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ghent University | College/University | Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Graduate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree Corporate Officer/Principal | |
| ESSEC Business School | College/University | Graduate Degree | |
MyCartis NV
 MyCartis NV BiotechnologyHealth Technology MyCartis NV develops technologies for healthcare personalization needs. It offers Evalution, a multiplex analysis platform to develop protein and nucleic-acid based clinical biomarkers. The company provides disruptive solutions in the fields of clinical and translational research for various applications in the detection of proteins and nucleic acids, such as sandwich immunoassays, antibody assays, genotyping assays, and mutation analysis assays to customers and partners. It offers products for various disease areas, including cell signalling, cardiovascular, oncology, and preeclampsia. The company was founded by Koen Kas in August 2004 and is headquartered in Ghent, Belgium. | Biotechnology | Chief Executive Officer Director/Board Member | |
Linklaters de Bandt
 Linklaters de Bandt Miscellaneous Commercial ServicesCommercial Services Part of Linklaters LLP, Linklaters de Bandt is a Belgian company that provides legal services. The company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MedPole SA/NV | Chief Operating Officer Director of Finance/CFO | ||
| Université Catholique de Louvain | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
St. Christopher's Hospital for Children LLC
 St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA. | Medical/Nursing Services | Corporate Officer/Principal | |
FlandersBio vzw
 FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
DIAsource ImmunoAssays SA
 DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Director of Finance/CFO | |
AstraZeneca NV
 AstraZeneca NV Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, AstraZeneca NV operates as a Belgian biopharmaceutical company. The company is based in Groot Bijgaarden, Belgium. AstraZeneca was founded in 1999. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Biotechnology | Chief Executive Officer | |
| Advanced Therapies Consulting Limited | Chief Executive Officer | ||
| Harvard Law School | College/University | Graduate Degree | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
PetSerCo BV
 PetSerCo BV Financial ConglomeratesFinance PetSerCo BV operates as an investment vehicle. The company is headquartered in Wavre, Belgium. | Financial Conglomerates | Director/Board Member | |
| IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Cellular Therapeutics Ltd.
 Cellular Therapeutics Ltd. BiotechnologyHealth Technology Part of Instil Bio, Inc., Cellular Therapeutics Ltd. is a British company that manufactures cell therapy products. The company is based in Manchester, UK. The company was founded by David Gilham. | Biotechnology | Founder | |
| LYELL IMMUNOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
Leucid Bio Ltd.
 Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer | |
| UPMC Children's Hospital of Pittsburgh | Corporate Officer/Principal | ||
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Appia Bio, Inc. is an early stage biotechnology company based in an undisclosed location. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. The American company utilizes the biology of lymphocyte development with chimeric antigen receptor (CAR) and T cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-NKT) or gamma delta T cells from hematopoietic stem cells (HSCs) with its ACUA (Appia Cells Utilized for Allogeneic) technology platform. The ACUA platform was developed from groundbreaking research in the laboratory of Lili Yang, Ph.D., at the University of California, and collaboration with Appia Bio's other scientific founders, David Baltimore, Ph.D. at Caltech and Pin Wang, Ph.D. at the University of Southern California. The company was founded in 2020 by Jeffrey S. Wiezorek, David Baltimore, Jeenjoo Kang, Lili Yang, Edmund Kim, and Pin Wang. Jeenjoo Kang has been the CEO since 2020. | Biotechnology | Director/Board Member | |
Aniserco NV (Flemish Region)
 Aniserco NV (Flemish Region) Specialty StoresRetail Trade Aniserco NV is a private company based in Dilbeek, Belgium. Aniserco NV operates under the brand name Tom&Co, offering a wide range of high-quality pet products, including food, grooming accessories, toys, and litter, among others. The Belgian company provides a practical click & collect service and fast delivery to take care of pets. With trusted brand products and expert advice, Tom&Co is an ideal partner for pet owners to take care of their faithful companions. The company was founded in 1991, and Thierry Le Grelle has been the CEO of the company since 2022. | Specialty Stores | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 22 |
| Belgien | 19 |
| Vereinigtes Königreich | 7 |
| Frankreich | 5 |
| Deutschland | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 16 |
| Commercial Services | 4 |
| Retail Trade | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 50 |
| Corporate Officer/Principal | 43 |
| Director of Finance/CFO | 20 |
| Independent Dir/Board Member | 15 |
| Graduate Degree | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Hilde Windels | 18 |
| Chris de Jonghe | 15 |
| Maria Koehler | 12 |
| Patrick Jeanmart | 10 |
| Charles Q. Morris | 10 |
| Margo Roberts | 10 |
| Philippe Dechamps | 10 |
| Stephen Rubino | 10 |
| Christian Homsy | 9 |
| Filippo Petti | 9 |
| Carri Duncan | 8 |
| Leif Langensand | 8 |
| J. Christopher LiPuma | 7 |
| Dominic Piscitelli | 7 |
| Georges Rawadi | 5 |
- Börse
- Insiders
- Philippe Nobels
- Unternehmensverbindungen